Nu Med Plus Stock Price on November 22, 2024
| NUMD Stock | USD 0.02 0 25.20% |
If you're considering investing in Nu-Med OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Nu-Med Plus stands at 0.02, as last reported on the 1st of January, with the highest price reaching 0.02 and the lowest price hitting 0.02 during the day. Nu Med Plus retains Efficiency (Sharpe Ratio) of -0.0445, which conveys that the firm had a -0.0445% return per unit of price deviation over the last 3 months. Nu-Med Plus exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nu-Med Plus' Information Ratio of (0.06), market risk adjusted performance of 0.6774, and Mean Deviation of 8.46 to check out the risk estimate we provide.
Nu-Med OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Nu-Med |
Sharpe Ratio = -0.0445
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NUMD |
Estimated Market Risk
| 13.98 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.62 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nu-Med Plus is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nu-Med Plus by adding Nu-Med Plus to a well-diversified portfolio.
Related Headline
ReShape Lifesciences Headline on 22nd of November 2024
Disposition of tradable shares by Thomas Stankovich of ReSha... by MacroaxisInsider
Filed transaction by ReShape Lifesciences Officer Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Nu-Med Plus Valuation on November 22, 2024
It is possible to determine the worth of Nu-Med Plus on a given historical date. On November 22, 2024 Nu-Med was worth 0.0171 at the beginning of the trading date compared to the closed value of 0.016. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Nu-Med Plus otc stock. Still, in general, we apply an absolute valuation method to find Nu-Med Plus' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nu-Med Plus where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Nu-Med Plus' related companies.
| Open | High | Low | Close | Volume | |
| 0.02 | 0.02 | 0.02 | 0.02 | 1.00 | |
11/22/2024 | 0.02 | 0.02 | 0.02 | 0.02 | 15,475 |
| 0.02 | 0.02 | 0.01 | 0.02 | 29,900 |
| Backtest Nu-Med Plus | | | Nu-Med Plus History | | | Nu-Med Plus Valuation | Previous | Next |
Nu-Med Plus Trading Date Momentum on November 22, 2024
| On November 25 2024 Nu Med Plus was traded for 0.02 at the closing time. The top price for the day was 0.02 and the lowest listed price was 0.01 . The trading volume for the day was 29.9 K. The trading history from November 25, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 24.38% . The trading delta at closing time against the current closing price is 13.13% . |
Nu Med Plus Fundamentals Correlations and Trends
By evaluating Nu-Med Plus' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Nu-Med Plus' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Nu-Med financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Nu-Med Plus OTC Stock history
Nu-Med Plus investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Nu-Med is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Nu Med Plus will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Nu-Med Plus stock prices may prove useful in developing a viable investing in Nu-Med Plus
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. Nu-Med Plus, Inc. was incorporated in 2011 and is headquartered in Salt Lake City, Utah. Nu Med operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 2 people.
Nu-Med Plus OTC Stock Technical Analysis
Nu-Med Plus technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Nu-Med Plus Period Price Range
Low | January 1, 2025
| High |
0.00 | 0.00 |
Nu Med Plus cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Nu-Med Plus January 1, 2025 Market Strength
Market strength indicators help investors to evaluate how Nu-Med Plus otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nu-Med Plus shares will generate the highest return on investment. By undertsting and applying Nu-Med Plus otc stock market strength indicators, traders can identify Nu Med Plus entry and exit signals to maximize returns
Nu-Med Plus Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Nu-Med Plus' price direction in advance. Along with the technical and fundamental analysis of Nu-Med OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Nu-Med to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.86) | |||
| Total Risk Alpha | (0.87) | |||
| Treynor Ratio | 0.6674 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Nu-Med OTC Stock analysis
When running Nu-Med Plus' price analysis, check to measure Nu-Med Plus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu-Med Plus is operating at the current time. Most of Nu-Med Plus' value examination focuses on studying past and present price action to predict the probability of Nu-Med Plus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu-Med Plus' price. Additionally, you may evaluate how the addition of Nu-Med Plus to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |